Overview Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial Status: Completed Trial end date: 2006-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether the administration of risperidone is effective in the treatment of selective serotonin reuptake inhibitor (SSRI)-resistant post-traumatic stress disorder (PTSD) in civilians. Phase: Phase 1/Phase 2 Details Lead Sponsor: Emory UniversityCollaborator: Janssen, LPTreatments: RisperidoneSertraline